SIGNIFICANCE OF BASELINE ACE ACTIVITY IN PATIENTS WITH METABOLIC SYNDROME WHEN ADMINISTRATION OF ACE INHIBITORS AND IMIDAZOLINE AGONISTS IS CONSIDERED
Significance of baseline ACE activity in patients with metabolic syndrome when administration of ACE inhibitors and imidazoline agonists is considered.
Saved in:
Main Authors: | T. V. Aparina, A. N. Britov, E. A. Dilakyan, V. A. Metelskaya, O. A. Gomazkov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2001-04-01
|
Series: | Российский кардиологический журнал |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/2147 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMBINATION OF ACE INHIBITOR WITH AGONIST OF I1 -IMIDAZOLINE RECEPTORS: NEW OPPORTUNITIES FOR ANTIHYPERTENSIVE THERAPY
by: S. V. Nedogoda
Published: (2016-12-01) -
EVIDENCE-BASED CHOICE OF ACE INHIBITORS
by: G. E. Gendlin, et al.
Published: (2012-08-01) -
ACE inhibitors in patients with heart failure
by: O. P. Shevchenko, et al.
Published: (2008-10-01) -
Spirapril – a modern ACE inhibitor
by: V. M. Gorbunov
Published: (2005-06-01) -
ACE inhibitors in the treatment of paroxysmal atrial fibrillation
by: B. A. Tatarsky
Published: (2005-06-01)